To study the role of hepatitis C virus in non-A, non-B chronic hepatitis, 49 liver biopsy samples from 40 patients with non-A, non-B chronic hepatitis and 9 control patients were analyzed by complementary DNA/polymerase chain reaction. Two segments of the HCV genome, one in the nonstructural region
Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non-A, non-B chronic liver disease
β Scribed by Masayuki Kurosaki; Nobuyuki Enomoto; Chifumi Sato; Naoya Sakamoto; Yuji Hoshino; Hideaki Haritani; Fumiaki Marumo
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 554 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
The relationship between plasma hepatitis C virus (HCV) RNA levels, antibody positivity, and hepatocellular damage were studied i n 41 patients with non-A, non-B chronic liver disease. The patients were placed into t w o groups according to the plasma levels of HCV-RNA: plasma HCV-RNA level was estimated as high when detected by a one stage polymerase chain reaction (PCR) and as low when detectable only after a two stage PCR. Anti-HCV (first and second generation assays) and anti-GOR were also measured. The mean alanine aminotransferase (ALT) level of the high HCV-RNA group was 11 5 2 62 IUA, whereas that of the low HCV-RNA group was 59 * 37 IUA (P < 0.05). Patients with ALT levels above 100 lUil had invariably a high level of HCV-RNA. There were no differences in clinical features in relation to the presence of anti-GOR or anti-HCV. Circulating HCV-RNA levels but not anti-HCV or anti-GOR antibodies correlated with hepatocellular damage.
π SIMILAR VOLUMES
The aim of this work was to study the presence of the hepatitis GB virus type C (HGBV-C) in liver and serum samples of children with chronic viral hepatitis, the time course of changes in viral RNA, and the possible acquisition routes of infection. Frozen serum and liver samples from 58 children wit